Director, Obesity Commercial & Brand Marketing
Zurich, Switzerland Zurich, CH
Your impact begins here
As Director, Obesity Commercial and Brand Marketing, IOSO, you will shape the future of Novo’s obesity business across International Operations. Combining deep consumer understanding with strategic commercial leadership, you will drive bold brand strategies, accelerate oral semaglutide adoption and unlock new opportunities for sustainable portfolio growth. You will lead the development of compelling, insight-driven brand plans that connect consumer needs, scientific innovation and commercial excellence, empowering markets to win in an increasingly competitive environment. Ultimately, your leadership will help more people living with obesity access innovative treatments and achieve better, lasting health outcomes.
What you’ll bring
You combine commercial judgement with the ability to lead people and bring senior stakeholders with you. You will have:
-
A university degree in business, marketing, life sciences or related discipline.
-
At least 10 years of progressive commercial, marketing or general management experience, including substantial senior leadership responsibility in pharmaceuticals, consumer healthcare or a closely related regulated healthcare sector.
-
A proven track record of developing and executing end-to-end brand strategies, competitive responses, product launches and growth initiatives across multiple markets.
-
Strong experience in consumerisation, trade marketing, pharmacy channels and digital or provider-led healthcare ecosystems.
-
Proven experience in developing and leading integrated, insight-driven marketing campaigns, from creative strategy and content development
-
Strong experience in B2B and B2B2C commercial models, including strategic partnerships, channel development and driving growth through healthcare providers, pharmacies and digital platforms.
-
Proven people leadership and the ability to influence senior stakeholders in a complex matrix organisation.
-
Strong strategic judgement, financial acumen, analytical capability, and clear executive communication.
Useful, but not essential:
-
Hands-on Rx-to-OTC switch experience, including commercial strategy, consumer proposition, regulatory collaboration and retail activation.
-
Experience in obesity, cardiometabolic disease or weight management.
-
A background in medical wellness, aesthetics, consumer health, retail pharmacy or direct-to-consumer healthcare.
-
Experience in international or regional portfolio management, lifecycle management and loss-of-exclusivity planning.
What you’ll do
You will set the direction for obesity brands in International Operations (excluding the US) and make sure it turns into excellent execution in the markets.
-
Own the end-to-end obesity brand strategy, annual brand plan and brand narrative, translating global direction into clear International Operations priorities and affiliate execution.
-
Drive the oral semaglutide launch acceleration and sustained uptake across International Operations, with clear source-of-business strategies, and go-to-market plans
-
Lead integrated HCP, consumer and omnichannel marketing, and position current and future obesity assets with a clear view of growth opportunities.
-
Shape lifecycle and loss-of-exclusivity strategies, anticipate competitor moves, and identify, quantify and prioritise new growth opportunities across markets, patient segments and channels.
-
Lead the move towards a more consumer-oriented model, including trade and pharmacy strategies and opportunities in digital health, telehealth, e-commerce and B2B2C partnerships, while keeping appropriate medical and regulatory safeguards in place.
-
Build an insights agenda that maps the full patient funnel, from awareness to persistence, discontinuation and restarts, and turn it into differentiated propositions, evidence-based forecasts and clear commercial KPIs.
-
Lead, coach and develop a high-performing marketing team, with clear accountability and a culture grounded in patient safety, scientific integrity and measurable business impact.
Who you’ll work with
You will lead the Obesity Commercial and Brand Marketing team in IOSO, part of International Operations, where colleagues work across markets to serve people around the world and help improve health at scale. You will report to AVP of CardioMetabolic Marketing, International Operations.
Your closest partners will be global brand teams, IOSO teams, regions and key affiliates. You will also work with senior leadership and colleagues in medical, market access, regulatory, legal, finance, supply and business development, as well as external agencies, vendors and congress partners.
You will be based in Zurich, with responsibility across International Operations (excluding the US). The role asks you to create clarity in a complex international matrix, agree on priorities with the right people, and move from decision to delivery at pace.
What you can expect here
You will be trusted to own a significant part of Novo’s obesity business, with clear performance expectations and the support to perform at your best. You will have the room to make your voice heard, challenge convention and shape strategic choices that affect many markets.
The role offers broad exposure across the value chain, from upstream project discussions and clinical programmes through to launch and in-market execution. You will grow through that breadth, through your team and through the people you work with every day.
Start now
Your impact begins today. If you are ready to turn insight into growth and help more people access obesity treatment, apply for the Head of Obesity Commercial and Brand Marketing, IOSO role by Nov 30. Applications are reviewed on an ongoing basis, so we encourage you to apply as soon as possible.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.